NETRIS Pharma R&D activity is based on the fundamental research results generated by the “Apoptosis, Cancer and Development” Laboratory.

NETRIS Pharma and the “Apoptosis, Cancer and Development” laboratory actively work together to :

Identify

new Dependence Receptors

Investigate

their role in cancer

Bring proof of concept studies 

supporting the therapeutic strategy

Develop therapeutic antibodies

for preclinical and clinical evaluation

For access to most recent publications :